Loading clinical trials...
Loading clinical trials...
A Randomized Phase II Dose Finding Study Of Thalidomide And Prednisone As Maintenance Therapy Following Autologous Stem Cell Transplant In Patients With Multiple Myeloma
Conditions
Interventions
prednisone
thalidomide
Locations
64
United States
St. Mary's/Duluth Clinic Health System
Duluth, Minnesota, United States
Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada
Lethbridge Cancer Clinic
Lethbridge, Alberta, Canada
Burnaby Hospital Regional Cancer Centre
Burnaby, British Columbia, Canada
Nanaimo Cancer Clinic
Nanaimo, British Columbia, Canada
Penticton Regional Hospital
Penticton, British Columbia, Canada
Start Date
July 12, 2000
Primary Completion Date
May 3, 2002
Completion Date
December 15, 2008
Last Updated
April 2, 2020
NCT01137825
NCT07319897
NCT00049673
NCT00305812
NCT00003353
NCT00002878
Lead Sponsor
NCIC Clinical Trials Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions